Tuvia Ben Gal Selected Research

Type Im Congenital Disorder Of Glycosylation

3/2013

From discrete dilated cardiomyopathy to successful cardiac transplantation in congenital disorders of glycosylation due to dolichol kinase deficiency (DK1-CDG).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tuvia Ben Gal Research Topics

Disease

22	Heart Failure 01/2022 - 03/2005
4	Type 2 Diabetes Mellitus (MODY) 01/2022 - 10/2019
3	Hemorrhage 12/2021 - 03/2005
2	COVID-19 01/2022 - 06/2020
2	Infections 01/2020 - 04/2014
2	Cardiomyopathies (Cardiomyopathy) 01/2019 - 03/2005
1	Sudden Death 01/2022
1	Pulmonary Hypertension 01/2022
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 01/2022
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2022
1	Myocardial Infarction 12/2021
1	Cardiogenic Shock 12/2021
1	Thrombosis (Thrombus) 12/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2020
1	Takotsubo Cardiomyopathy 01/2020
1	Atrial Fibrillation 10/2019
1	Mitral Valve Insufficiency (Mitral Regurgitation) 10/2019
1	Transthyretin-Related Hereditary Amyloidosis 10/2019
1	Myocarditis (Carditis) 09/2019
1	Weight Gain 03/2016
1	Morbid Obesity 03/2016
1	Dyslipidemias (Dyslipidemia) 03/2016
1	Hypertension (High Blood Pressure) 03/2016
1	Congenital Disorders of Glycosylation 03/2013
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 03/2013
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 03/2013
1	Death (Near-Death Experience) 03/2013

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2022
3	Glucose (Dextrose)FDA LinkGeneric 11/2020 - 10/2019
3	SodiumIBA 11/2020 - 10/2019
3	SymportersIBA 11/2020 - 10/2019
2	Pharmaceutical PreparationsIBA 01/2022 - 12/2020
2	empagliflozinIBA 11/2020 - 01/2020
2	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2020 - 01/2020
2	CanagliflozinIBA 11/2020 - 01/2020
2	dapagliflozinIBA 11/2020 - 01/2020
1	4-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA 01/2022
1	Sildenafil Citrate (Viagra)FDA Link 01/2022
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2022
1	Neprilysin (Neutral Endopeptidase)IBA 01/2022
1	Sodium-Glucose Transport ProteinsIBA 01/2022
1	ertugliflozinIBA 11/2020
1	omega-Chloroacetophenone (Mace)IBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2019
1	UlaritideIBA 11/2019
1	Simendan (Levosimendan)IBA 11/2019
1	RivaroxabanIBA 10/2019
1	tafamidisIBA 10/2019
1	Immune Checkpoint InhibitorsIBA 09/2019
1	Capsules (Microcapsules)IBA 12/2018
1	Adenosine Triphosphate (ATP)IBA 04/2014
1	Congenital disorder of glycosylation type 1AIBA 03/2013
1	Type Im Congenital Disorder Of GlycosylationIBA 03/2013
1	Factor VIIa (Activated Factor VII)IBA 03/2005
1	Factor VII (Proconvertin)IBA 03/2005

Therapy/Procedure

13	Therapeutics 01/2022 - 03/2013
11	Heart-Assist Devices 01/2022 - 03/2005
5	Heart Transplantation (Grafting, Heart) 03/2020 - 03/2005
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2022 - 10/2019
1	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2021
1	Induced Hypothermia 12/2021
1	Deprescriptions 12/2020
1	Palliative Care (Palliative Therapy) 12/2020
1	Drug Therapy (Chemotherapy) 10/2019
1	Bariatric Surgery 03/2016
1	Art Therapy 02/2011